newsfilter
← Latest News
Business Wire·

Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights

- Closed registered direct offering for aggregate gross proceeds of US$175 million (the "Registered Direct Offering") led by a syndicate of prominent biopharmaceutical institutional investors - - On track to report